ECM molecules, along with their cell surface receptors and adhesion molecules, are associated with a range of central nervous system disorders, such as Alzheimer’s disease, schizophrenia, epilepsy, multiple sclerosis, addiction, and PD [49]. This evidence concerns the gene CD177 and Parkinson disease.